Yanyan Ping
Overview
Explore the profile of Yanyan Ping including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi A, Yan M, Pang B, Pang L, Wang Y, Lan Y, et al.
BMC Immunol
. 2023 Dec;
24(1):52.
PMID: 38082384
Background: Cellular states of different immune cells can affect the activity of the whole immune microenvironment. Methods: Here, leveraging reference profiles of microenvironment cell states that were constructed based on...
2.
Dou R, Kang S, Yang H, Zhang W, Zhang Y, Liu Y, et al.
Biol Direct
. 2023 Nov;
18(1):79.
PMID: 37993951
Background: MicroRNAs (miRNAs) play critical roles in cancer initiation and progression, which were critical components to maintain the dynamic balance of competing endogenous RNA (ceRNA) networks. Somatic copy number alterations...
3.
Xu J, Pang B, Lan Y, Dou R, Wang S, Kang S, et al.
Mol Oncol
. 2023 Jul;
17(11):2472-2490.
PMID: 37491836
High heterogeneity in genome and phenotype of cancer populations made it difficult to apply population-based common driver genes to the diagnosis and treatment of cancer individuals. Characterizing and identifying the...
4.
Yan H, Zhu J, Ping Y, Yan M, Liao G, Yuan H, et al.
Stem Cells
. 2022 Dec;
41(2):111-125.
PMID: 36583266
Glioblastoma stem cells (GSCs) contributed to the progression, treatment resistance, and relapse of glioblastoma (GBM). However, current researches on GSCs were performed usually outside the human tumor microenvironment, ignoring the...
5.
Lan Y, Liu W, Hou X, Wang S, Wang H, Deng M, et al.
Hum Mutat
. 2022 Oct;
43(12):2187-2204.
PMID: 36218010
The clonal mutations in driver genes enable cells to gradually acquire growth advantage in tumor development. Therefore, revealing the functions of clonal driver gene mutations is important. Here, we proposed...
6.
Wang L, Yu L, Shi J, Li F, Zhang C, Xu H, et al.
Sci Rep
. 2022 Jun;
12(1):10641.
PMID: 35739271
Differences in genetic molecular features including mutation, copy number alterations and DNA methylation, can explain interindividual variability in response to anti-cancer drugs in cancer patients. However, identifying genetic alteration-driven genes...
7.
Cheng P, Lan Y, Liao J, Zhao E, Yan H, Xu L, et al.
Genomics
. 2022 Jun;
114(4):110412.
PMID: 35714828
Tumors are genetically heterogeneous and many mutations are actually present in subclonal populations. The clonal status of mutations is valuable for accurate prognosis, clinical management. The aim of this study...
8.
Xu L, Zhu S, Lan Y, Yan M, Jiang Z, Zhu J, et al.
Brief Bioinform
. 2022 Mar;
23(3).
PMID: 35229870
Interaction between tumor cells and immune cells determined highly heterogeneous microenvironments across patients, leading to substantial variation in clinical benefits from immunotherapy. Somatic gene mutations were found not only to...
9.
Yan M, Hu J, Ping Y, Xu L, Liao G, Jiang Z, et al.
Front Immunol
. 2021 Nov;
12:758288.
PMID: 34804045
The infiltration of tumor-reactive T cells in the tumor site is associated with better survival and immunotherapy response. However, tumor-reactive T cells were often represented by the infiltration of total...
10.
Yan M, Hu J, Yuan H, Xu L, Liao G, Jiang Z, et al.
Mol Ther Nucleic Acids
. 2021 Nov;
26:1115-1129.
PMID: 34786214
T cells exhibit heterogeneous functional states, which correlate with responsiveness to immune checkpoint blockade and prognosis of tumor patients. However, the molecular regulatory mechanisms underlying the dynamic process of T ...